Categories
Bad science Bioethics Cancer Medicine Quackery Skepticism/critical thinking

Clínica 0-19 and IDOI: Not making DIPG history in Monterrey (part 4 of 4)

Orac has finally located the abstract published by Dr. Alberto Siller and Alberto Garcia, who are selling intra-arterial chemotherapy for the deadly brain tumor DIPG. Let’s just say that he’s…less than impressed by the results. Shades of Burzynski!

Categories
Bioethics Medicine Politics

Some final thoughts (for now) on right-to-try, the Stanislaw Burzynski of drug regulation laws

Right-to-try is now the law of the land. Unfortunately, it’s a law custom-made for the unethical who don’t mind taking advantage of the terminally ill.

Categories
Cancer Complementary and alternative medicine Medicine Pseudoscience Quackery

The dubious cancer “virotherapy” Rigvir returns with an equally dubious case report

Rigvir is a “virotherapy” from Latvia promoted by the International Virotherapy Center and, increasingly, by alternative cancer clinics. There is no convincing scientific evidence for its efficacy. That didn’t stop its advocates from presenting a case report. Not surprisingly, the case report isn’t convincing either.

Categories
Cancer Clinical trials Complementary and alternative medicine Medicine Politics Popular culture Pseudoscience Quackery Skepticism/critical thinking

As feared, Houston cancer quack Stanislaw Burzynski (mostly) slithers away from justice again

I’ve been blogging fairly regularly about Houston cancer quack Dr. Stanislaw Burzynski since 2011, and now the story is over…sort of. Unfortunately, as you will see, the ending is far from ideal. It is, however, somewhat better than I had feared it might be. What I’m referring to, of course, is the final ruling of […]

Categories
Medicine Politics Popular culture

“Right-to-try” in 2019: Still a failure, still all about the Benjamins (and weakening the FDA)

Federal “right-to-try” legislation was passed and signed into law by President Trump over a year ago. Advocates promised that lots of terminally ill people who were dying then would be saved by having the right to “try” experimental therapies outside of the context of clinical trials. That has not happened. This should come as no surprise, because right-to-try was never about getting experimental drugs to dying patients. It was always about weakening the FDA and making money.